Maryland State Retirement & Pension System’s Apellis Pharmaceuticals APLS Stock Holding History

Maryland State Retirement & Pension System’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,816	Closed	-$837K	–	1426
2026 Q1	$837K	Buy	+20,816	New	+$449K	0.02%	568
2024 Q3	–	Sell	-7,881	Closed	-$302K	–	1527
2024 Q2	$302K	Hold	7,881	–	–	0.01%	1380
2024 Q1	$391K	Hold	7,881	–	–	0.01%	1252
2023 Q4	$472K	Hold	7,881	–	–	0.01%	1182
2023 Q3	$300K	Hold	7,881	–	–	0.01%	1357
2023 Q2	$718K	Buy	+7,881	New	+$680K	0.02%	837

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Maryland State Retirement & Pension System's APLS Position: Q2 2026 in Review

Maryland State Retirement & Pension System sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 20,816 shares — an estimated $837K sold.

Maryland State Retirement & Pension System first reported a position in APLS in Q2 2023 and held it in 6 quarters. The position peaked at $837K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Maryland State Retirement & Pension System reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Maryland State Retirement & Pension System sold 20,816 Apellis Pharmaceuticals shares in Q2 2026, an estimated $837K.
Maryland State Retirement & Pension System first reported a position in Apellis Pharmaceuticals in Q2 2023 and held it in 6 quarters.
Maryland State Retirement & Pension System's Apellis Pharmaceuticals position peaked at $837K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.